$262.34Pre-market+13.67% · 3M
Moving avg
1W+1.27%
1M+1.20%
3M+13.21%
6M+8.30%
YTD+25.81%
1Y+50.98%
3Y+50.40%
5Y+48.89%
52-week range
$164.2392% of range$269.43
Company health
Value0/6
Growth2/6
Profitability6/6
Health3/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Strong 28% net margin
- High return on equity (2574%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$628.65B
Enterprise value
$662.67B
P/E ratio (TTM)
30.45x
P/S ratio (TTM)
6.47x
EV/EBITDA
20.76x
Per share & returns
EPS (TTM)
$8.62
Dividend yield
1.99%
Beta (1Y)
0.23
30-day change
+1.20%
Trading
Volume (24h)
3.26M
Previous close
$259.80
Shares outstanding
2.41B
About Johnson & Johnson
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Symbol
JNJ
Johnson & Johnson is a mega-cap healthcare company in the Drug Manufacturers - General industry. Its shares are listed on NYSE (United States) and trade under the ticker JNJ.
Frequently asked questions
What is Johnson & Johnson's market cap?
Johnson & Johnson (JNJ) has a market capitalization of $628.65B.
What is Johnson & Johnson's P/E ratio?
Johnson & Johnson trades at a price-to-earnings (P/E) ratio of 30.45.
What exchange does JNJ trade on?
JNJ trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 363.60-0.52%
$356.07B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.70-0.40%
$289.26B cap
AstraZeneca PLCLON: AZN
£116.28-0.63%
$243.12B cap
Amgen Inc.AMGN
$416.18+0.45%
$224.62B cap